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UNIT A28.1Contrast-Enhanced Renal MRA
BASIC
PROTOCOL
Magnetic resonance angiography (MRA) scans can be run at a range of field strengths
with varying degrees of success. The success of the technique in imaging arteries is based
on several factors and will be discussed in Critical Parameters and Troubleshooting.
Although the pulse sequence parameters are defined with respect to 1.5 T scanners, the
actual parameters differ according to available gradient strength. Therefore, TR, TE, and
bandwidths are adjusted for maximum vascular signal. The advantage in using higher
gradients is to obtain images with higher temporal resolution, a useful tool in time-re-
solved imaging studies. The entire protocol consists of four different pulse sequences.
Sequence 2 is used to survey kidneys for additional morphologic information that is not
obtained from MRA sequences. The total scan time should be less than or equal to about
30 min.
Imaging hardware necessary for performing renal MRA is listed in Table A28.1.1.
Available gradient strength will depend on the scanner, and accordingly, the echo times,
repeat times, and bandwidths may be varied.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
Materials
Normal saline (0.9% NaCl), sterile
Extravascular contrast agent (e.g., Magnevist, Omniscan, or Prohance), volume
estimated using patient weight (usual amount is based on a single dose, 0.1
mmol/kg)
Disposable contrast-agent syringes and i.v. line
Power injector
Set up patient and equipment
1. Interview and screen the patient to ensure that he or she has no contraindications to
an MR examination. Contraindications include a cardiac pacemaker or defibrillator,
intracerebral aneurysm clip, or ferromagnetic materials in or near vital structures,
including the eyes. Also be sure to find out if the patient has any health condition that
may require the presence of emergency equipment such as cardiac monitor or oxygen.
Since a contrast agent will be injected, obtain an allergy history.
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Table A28.1.1 Equipment and Parameters for Renal Artery MRA
Coil type Phased-array or torso-array coil with at
least 4 channels
Gradient coil strength 25 mT/m for Vision (40 mT/m for Sonata)
Cardiac gating No
Peripheral gating No
Oxygen Yes, if patient finds it difficult to hold
his/her breath for >15 sec, then
administer 2 liters via a nasal cannula
Power injector Yes
Contrast agents Yes (e.g., Magnevist, Omniscan, or
Prohance)
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Generally, standard screening forms (see APPENDIX 1) are used for all patients scanned in
a magnetic resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(2001) for a discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing,
as well as other items as described above.
2. If the procedure is a research protocol, have the patient sign any consent form as
required by the hospital research administration.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earplugs and headphones are used to protect the ears from the loud sound
produced by the gradients, the patient will be asked to wear these devices, but will
be able to communicate with you at any time during the imaging.
b. The patient may be given a safety squeeze-bulb or similar equipment to request
assistance at any time; demonstrate how this works.
c. For good results, the patient should not talk, and should avoid or minimize other
movement during each scan—i.e., as long as the banging sounds continue.
Between scans, talking is allowed in most cases, but should be avoided when
comparative positional studies are being performed; the patient will be informed
when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. Educate the patient on how to hold his or her breath at the end of deep inspiration.
Practice the breath-hold method with the patient. Advise the patient of the importance
of not moving during the data acquisition periods and not taking deep breaths during
the non-breath-hold acquisitions.
Patients are instructed to take a breath in, blow it out, take a breath in again, relax,and
hold it. This allows images to be obtained in mid-respiratory cycle (∼15 to 20 sec will be
required for each breath-hold for each 3-D acquisition). Some of the newer sequences, such
as true FISP (true fast imaging with steady-state free precession), may require shorter
breath-holds. Breath holding is critical to obtaining motion-free images. Most patients find
it easier to hold their breath following a maximum inspiration cycle. At the authors’
institution, patients are asked to hold their breath following a deep inspiration.
7. Have the patient mount onto the table. Either before or right after the patient lies
down, set up any triggering devices or other monitoring equipment that is to be used.
8. Establish an intravenous (i.v.) line from which the contrast agent can be injected, and
attach the i.v. line securely to the patient so that movement into or out of the magnet
will not pull at the patient’s arm.
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It is preferable to insert the i.v. line prior to imaging and to leave the patient in the magnet,
so that there is no intervening motion between the scans run before and after contrast agent
injection. Also, it is preferable to keep-veins-open (KVO) so that there are no air bubbles
in the i.v. line.
9. Estimate the amount of contrast agent to be used based on patient weight. Set up both
contrast-agent and saline syringes on the injector.
A general rule is to use 1 ml contrast agent for every 10 lb. of patient weight when injecting
as a single dose (0.1 mmol/kg), followed by 15 ml saline to flush the contrast agent.
10. Once the patient is on the table, place the anterior phased-array or torso-array coil.
Center the patient’s kidneys in the phased-array coil and fix it with the Velcro or
buckle straps provided by the manufacturer. Make sure that the phased-array body
coil (and spine coil if necessary) are plugged in.
For some systems, it will be important that the patient lie within the center of the spine
coil,which may be the posterior elements for the phased-array coil system.
11. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
12. Use the laser light available on most systems to center the phased-array coil or
torso-array coil at the “0" location and move the patient into the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then returned to the same position as before without
jeopardizing the positioning of one scan relative to another.
13. Assess the need for supplementary oxygen to improve the breath-holding capacity.
If the patient is not able to hold his or her breath, administer oxygen (2 liters) through
a nasal cannula.
For severely ill patients who cannot hold their breath, cannulas are necessary for basic
breath-hold studies. If the patient still cannot hold his/her breath during the scanning,
imaging can be performed during free breathing in which scan time is considerably reduced
using low acquisition matrix size (number of data points collected) as described in
Anticipated Results (breath-holding). This will improve temporal resolution at the expense
of spatial resolution.
Sequence 1: Rapid three-plane positioning localizers
14. Ask the patient to take a breath in, blow it out, take a breath in again, relax, and
hold it.
15. To validate the correct position for imaging, run the localizer (or pilot) scan of the
system according to Table A28.1.2.
This is done using fast-gradient-recalled imaging sequences with three orientations,
prescribed with multiple slices in each orientation. Refer to the manufacturer’s specifica-
tions for standard default settings and swap as necessary. It is preferable to obtain
localizers in a breath-hold mode. The subsequent placement of an imaging slab will be
more accurate with breath-hold localizers.
Sequence 2: Transverse true-FISP imaging
16. Bring up the sequence for a rapid transverse scan using the parameters defined in
Table A28.1.3.
At the authors’ institution, a true FISP sequence is used to survey both kidneys in a
transverse orientation. This allows for visualizing any disease processes, such as cysts in
the kidneys.
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Table A28.1.2 Clinical Imaging Parameters for Sequence 1 (Rapid Localizers)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Transverse, sagittal, coronal
Central slice or volume center Xyphoid
Echo time (TE) 6.5 msec (1.56 msec)a
Receiver bandwidth (RBW) 390 Hz/pixel (781 Hz/pixel)a
Repeat time (TR) 15 msec (3.12 msec)a
Delay time (TD) 0 msec
Flip angle (FA) 30° (55°)a
Fields of view (FOVx, FOVy) 450 mm, 450 mm (400 mm, 400 mm)a
Resolution (∆x, ∆y) 1.76 mm , 3.52 mm (1.56 mm, 1.68
mm)a
Number of data points collected (Nx, Ny) 256, 128 (256, 238)a
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 5
Slice gap Variable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Saturation pulses No
Scan time 10 sec (12 sec)a
aInformation in parentheses refers to parameters for a Sonata scanner. Scan time for the Sonata is based
on 15 slices.
Table A28.1.3 Imaging Parameters for Sequence 2 (True-FISP Survey of Kidneys)
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Xyphoid
Echo time (TE) 2.3 msec (1.56 msec)a
Receiver bandwidth (RBW) 650 Hz/pixel (781 Hz/pixel)a
Repeat time (TR) 4.8 msec (3.12 msec)a
Delay time (TD) 0 msec
Flip angle (FA) 70° (55°)a
Fields of view (FOVx, FOVy) 350 mm, 350 mm (400 mm, 400 mm)a
Resolution (∆x, ∆y) 1.37 mm, 1.37 mm (1.56 mm, 1.68
mm)a
Number of data points collected (Nx, Ny) 256, 256 (256, 238)a
Display matrix (Dx, Dy) 256, 256 (256, 256)a
Slice thickness (∆z) 6 mm (6 mm)a
Number of slices 15 (15)a
Slice gap 1.2 mm (1.2 mm)a
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Saturation pulses No
Scan time 18 sec (11 sec)a
aInformation in parentheses refers to parameters for a Sonata scanner.
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17. Use the pilot (scout) images run earlier to locate both kidneys and set up imaging in
a transverse orientation.
18. Let the patient know you are ready to image during breath-hold state. Repeat step 14
and begin the scan during suspended respiration following inhalation.
Some of the newer sequences, such as true FISP, may require shorter breath-holds. In cases
where multiple breath-holds are needed, assess the need for supplementary oxygen to
improve the breath-holding capacity, and, if necessary, administer 2 liters of oxygen via a
nasal cannula. Advise the patient of the importance of not moving during the acquisition.
Sequence 3: Estimation of bolus arrival time (BAT)
19. Using orthogonal localizers (coronal and transverse), set up the imaging sequence
with parameters as described in Table A28.1.4 for estimating the bolus arrival time.
At the author’s institution, a rapid imaging pulse sequence is used with a nonselective
inversion pulse to null blood.
20. Position a single 10-mm slice in a transverse orientation near the renal hila.
21. Set up the power injector so that 2 ml of contrast agent will be injected followed by
15 ml of saline. Set up the injection rate at 2.5 ml/sec for both contrast agent and
saline injections.
The imaging allows for one image per second. By setting the number of repetitions in scans
to ∼40, upon visual inspection of each of these images, one can see the signal changing in
the abdominal aorta as the contrast agent transits through that section.
Table A28.1.4 Imaging Parameters for Sequence 3 (Bolus Arrival Time
Estimation)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Renal hilum
Echo time (TE) 2.4 msec (1.66 msec)a
Repeat time (TR) 5.8 msec (500 msec)a
Inversion time (TI) 300 msec (250 msec)a
Delay time (TD) 0 msec
Flip angle (FA) 12° (20°)a
Fields of view (FOVx, FOVy) 380 mm, 380 mm (400 mm, 400 mm)a
Resolution (∆x, ∆y) 1.48 mm, 2.97 mm (1.56 mm, 3.13
mm)a
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 1
Slice gap Not applicable
Number of acquisitions (Nacq) 1 (2)a
Number of repetitions 40
Swap read and phase encoding No
Saturation pulses No
Scan time ∼40 sec (40 sec)a
aInformation in parentheses refers to parameters for a Sonata scanner. The TR on the Sonata is based on
echoplanar sequence that includes 128 lines in 0.5 sec (1 slice). The number of acquisitions is doubled to
make 1 sec per slice.
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22. Instruct the patient to take in a deep breath and exhale, take in another deep breath,
relax, and hold it. Simultaneously start the injection and initiate the measurement
while the patient is holding his/her breath.
This procedure is preferably performed using a breath-hold mode. Even with proper
hyperventilation, patients may not be able to hold their breath beyond 25 sec. In such cases,
advise the patient to commence slow and shallow breathing when he/she cannot hold
his/her breath any longer.
On newer scanners (e.g., Siemens’ Sonata or Symphony or GE’s Signa Advantage), one
can reconstruct images in real time as they are acquired. This helps to visually confirm the
arrival of the contrast agent. At this point, abort the scan and stop the patient from holding
his/her breath.
Sequence 4: Pre-contrast MASK imaging
23. Using localizer or scout images, place a 3-D imaging slab in a coronal orientation
with the parameters described in Table A28.1.5 for acquiring MASK imaging for
subtraction.
24. Have the patient hyperventilate so that he/she is ready to hold his/her breath. Repeat
step 14. Start the scan according to the parameters listed in Table A28.1.5.
In some institutions, a MASK is obtained with 2 acquisitions (or NEX = 2) to provide better
subtraction of background tissue signal. Remember that the scan time is doubled in that case.
On a Sonata scanner using partial Fourier 6/8 along phase encoding direction, the scan
time is further reduced to 16 sec.
Table A28.1.5 Sequence 4 for Acquiring Pre-Contrast MASK Images
Patient position Supine
Scan type Spoiled 3-D-gradient echo
Imaging plane (orientation) Coronal
Central slice or volume center Xyphoid
Echo time (TE) 1.8 msec (1.22 msec)a
Receiver bandwidth (RBW) 390 Hz/pixel (390 Hz/pixel)a
Repeat time (TR) 4.6 msec (3.37 msec)a
Delay time (TD) 0 msec
Flip angle (FA) 25° (25°)a
Fields of view (FOVx, FOVy) 420 mm, 420 mm (390 mm, 341 mm)a
Resolution (∆x, ∆y) 0.82 mm, 1.62 mm (0.80 mm, 1.40
mm)a
Number of data points collected (Nx, Ny) 512, 260 (512, 246)a
Display matrix (Dx, Dy) 512, 512 (512, 512)a
Slice thickness (∆z) 2.5–3.00 mm; 1.25–1.5 mm after
interpolation (3.1 mm interpolated to 2
mm)a
Number of slices 20 (40 after interpolation); 26 (40 after
fractional interpolation)
Slice gap 0
Number of acquisitions (Nacq) 1 (or 2)
Number of repetitions 1
Swap read and phase encoding No
ZIP 2 Yes
Saturation pulses No
Scan time 23 sec (16 sec)ab
aInformation in parentheses refers to parameters for a Sonata scanner.
bThe scan times are doubled if Nacq = 2.
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Sequence 5: Contrast-enhanced MRA
Immediately following the MASK image reconstruction, the patient is ready to receive a
contrast agent for post-gadolinium (Gd) imaging using the same pulse sequence parame-
ters used in MASK imaging.
25. Set up the pulse sequence with the number of acquisitions (Nacq) = 1 and number of
repetitions (or measurements) = 2.
Typically, two repetitions are performed to provide both an arterial and a delayed phase,
which includes both arteries and veins. The first repetition (or first measurement) provides
the arterial phase and the second repetition (or second measurement) provides the venous
phase.
26. Set up the power injector with the remaining contrast agent (estimated based on
patient weight in step 9) followed by 15 ml of saline at an injection rate of 2.5 ml/sec
for both.
27. Estimate measurement start time (delay time) based on the method described in
Critical Parameters and Troubleshooting (see Effects of Bolus Timing; Equation
A28.1.3); or in UNIT A10.1.
On a power injector, one can set this delay time as a countdown time to remind the operator
when to initiate the pulse sequence.
Table A28.1.6 Imaging Parameters for Sequence 5 (Contrast-Enhanced Imaging)
Patient position Supine
Scan type Spoiled 3-D-gradient echo
Imaging plane (orientation) Coronal
Central slice or volume center Xyphoid
Echo time (TE) 1.8 msec (1.22 msec)a
Receiver bandwidth (RBW) 390 Hz/pixel (390 Hz/pixel)a
Repeat time (TR) 4.6 msec (3.37 msec)a
Delay time (TD) 0 msec
Flip angle (FA) 25° (25°)a
Fields of view (FOVx, FOVy) 420 mm, 420 mm (390 mm, 341 mm)a
Resolution (∆x, ∆y) 0.82 mm, 1.62 mm (0.80 mm, 1.40
mm)a
Number of data points collected (Nx, Ny) 512, 260 (512, 246)a
Display matrix (Dx, Dy) 512, 512 (512, 512)a
Slice thickness (∆z) 2.5–3.00 mm; 1.25–1.5 mm after
interpolation (3.1 mm interpolated to 2
mm)a
Number of slices 20 (40 after interpolation); 26 (40 after
fractional interpolation)
Slice gap 0
Number of acquisitions (Nacq) 1
Number of repetitions 2 (no pause between measurements)
Swap read and phase encoding No
ZIP 2 Yes
Saturation pulses No
Scan time 23 sec (16 sec)a
aInformation in parentheses refers to parameters for a Sonata scanner.
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28. Inform the patient to be ready to hold his/her breath. Inject the contrast agent. During
the delay time, between the start of the injection and the start of the measurement,
hyperventilate the patient, repeat step 14, and run sequence 5 according to the
parameters described in Table A28.1.6.
The power injector automatically flushes saline after the injection of the contrast agent.
Two repetitions (measurements) are performed back-to-back without any delay between
measurements. Therefore, the total scan time is doubled. Make sure that the patient is
sufficiently hyperventilated to hold his/her breath for the entire duration of the measure-
ment.
The first measurement provides images of arteries only and the second measurement
provides images with arteries and veins.
Post-processing
29. Prior to subjecting the data to a vessel rendering routine, perform the subtraction of
the pre-contrast MASK data (from sequence 4) from post-contrast imaging data (from
sequence 5).
If multiple measurements are performed, subtract MASK data from each of these sets.
30. Input these subtracted data to a vascular rendering program such as the maximum
intensity projection (MIP), which is available on the scanner.
Alternatively, volume rendering is used to render vessels using surface rendering loga-
rithms with some translucency. With tortuous vascular anatomy, this method has an
advantage over MIP in accurately reflecting vascular pathology.
COMMENTARY
Background Information
The prevalence of renal artery stenosis is
∼45% in patients with peripheral vascular dis-
ease (Iglesias et al., 2000). Renal artery stenosis
has long been recognized as a cause of hyper-
tension and progressive renal insufficiency.
Such a high prevalence demands techniques
that will provide sensitivity and specificity bet-
ter than 90%. Over the years, the technical
developments in the field of MR angiography
have tremendously improved the ability to
visualize vessels with sensitivity and specific-
ity well over 93% (Holland et al., 1996; Hany
et al., 1998; Schoenberg et al., 1998; Lee et al.,
1999). Over the past 10 years, MRA has been
suggested as a cost-effective alternative to digi-
tal subtraction angiography (DSA) and Dop-
pler sonography.
Among available MRA techniques, con-
trast-enhanced magnetic resonance angiogra-
phy (CE-MRA) is more robust and reproduc-
ible compared to traditional non-contrast-en-
hanced time-of-flight and phase-contrast
techniques. By virtue of its insensitivity to flow
artifacts and slab orientation, CE-MRA is an
ideal method to precisely depict the arterial
morphology in the assessment of renal artery
disease. The vascular signal increase is primar-
ily due to T1 reduction and is achieved by
introducing a paramagnetic contrast agent. The
end result is the reduction in signal loss from
intra-voxel phase dispersion and from in-plane
saturation. The principal advantage is that it
allows for placing the imaging slab in a coronal
orientation covering a larger field-of-view and
thinner partitions. In addition, the RF-spoiled
3-D-gradient recalled echo (GRE) sequence,
together with T1 shortening effects from the
contrast agent, leads to a further reduction in
the surrounding stationary tissue signal, thus
providing an MR luminogram.
Critical Parameters and
Troubleshooting
Why use a contrast agent?
The majority of pulse sequences used in
dynamic 3-D imaging require a short TR to
complete a measurement in a breath-held pe-
riod. There are several consequences of reduc-
ing the TR and TE that can work against the
inflow enhancement of the signal. When the
repeat time, TR, is shortened, the product of
flow velocity (v) and TR, which is the distance
traveled within a slice, becomes much
smaller than the thickness of the slice. As a
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result, spins in the blood experience many RF
pulses [n = d/(vTR), where n = no. of RF pulses
and d = slice thickness] while inside the same
slice (also see UNIT B7.3). This leads to saturation
of spin signal with a smaller contribution from
inflow enhancement. The mathematical simu-
lation of signal with an ultrashort TR (Fig.
A28.1.1) shows that when TR is reduced con-
siderably, the contrast between blood and the
surrounding tissue is very poor prior to injec-
tion (long T1) and dramatically improves fol-
lowing gadolinium injection (short T1).
However, blood/tissue contrast can be dra-
matically increased using a paramagnetic con-
trast agent. The increase in signal is due to the
fact that with contrast agent injection, there is
a dramatic reduction in T1 of blood spins, caus-
ing a rapid recovery of its magnetization. This
rapid recovery of magnetization between RF
pulses is crucial in increasing the net longitu-
dinal magnetization available during the sub-
sequent application of RF pulses, which results
in an overall increase in signal (Fig. A28.1.2).
Since it is the reduction in T1 and not the
time-of-flight effect that is the key to signal
improvement, imaging is truly orientation-in-
dependent. This may be helpful in imaging that
will acquire a larger FOV (coronal or sagittal
orientation) with a minimum number of parti-
tions.
Pulse sequence parameter optimization
The paramagnetic contrast agent is a gad-
olinium chelate, an extracellular agent, and its
concentration in blood rapidly decreases fol-
lowing injection during longer scan times. Ap-
proximately 50% of the injected contrast agent
is washed out from the blood pool during the
first pass, with ∼80% of the contrast agent
washing out of the blood pool within the first
5 min. Since, the concentration of gadolinium
is maximum during the first pass; it is best to
image arteries during this phase.
The optimization of the pulse sequence is,
therefore, dependent on several key parame-
ters: (1) the effective relaxation times (T1 and
T2) of blood spins during the first passage of
gadolinium agent during circulation; (2) the
circulation time and injection rate to determine
the exact time location of the peak bolus signal;
and (3) the correct flip angle that provides the
maximum signal (based on fixed short TR).
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Figure A28.1.1 A simulation of the variation in signal intensity as a function of TR. At a relatively
short TR, spins experience a relatively large number of RF pulses while within the slice. This results
in a slow recovery of longitudinal magnetization causing saturation in their signal. Therefore, as TR
is reduced, the relative contrast between unenhanced blood (T1 = 1200) and tissue (T1 = 750) is
considerably reduced. Experimental TR for rapid imaging is generally held for <5 msec. With a TR
<5 msec, there is no noticeable contrast between blood and tissue (long T1). However, shortening
T1 (∼50 msec) dramatically improves contrast between blood and tissue. Abbreviation: a.u., arbitrary
units.
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Although the above conditions vary from pa-
tient to patient, a qualitative understanding of
their effects can be understood by using the
following simple model (Earls et al., 1996;
Hany et al., 1997).
T1 and T2 at the region of interest (ROI)
during the first-pass
When the measurement time onset is set to
coincide with the first-pass contrast bolus arri-
val time at the ROI, the overall signal is based
on the effective relaxation times (T1, T2) of
protons in the blood at the ROI during data
acquisition. Since the recovery of magnetiza-
tion is based on the relative T1, the shorter the
T1, the stronger the signal. The relative change
in signal (contrast) is based on the differences
in T1 of the blood and tissue following contrast
agent injection. The effectiveness of gadolin-
ium in reducing T1 and T2 of blood is based on
its relaxivity (r1,2), a relationship between the
relaxation rate and the concentration of the
contrast agent. In addition, the circulatory con-
dition of the patient also influences the change
in relaxation times. The correlation between T1,
T2, post-injection and the T1, T2, prior to injec-
tion is based on the first-pass concentration of
gadolinium chelate and is described by the
following equation (Johansson and Ahlstrom,
1998; Shetty et al., 2000):
where R1,2pre−Gd is the relaxation rates (inverse of
T1 and T2) prior to injection and R1,2post−Gd is the
resulting relaxation rates (inverse of T1 and T2)
following injection, and r1,2 are the longitudinal
(r1) and transverse (r2) relaxivities of a param-
agnetic agent. Cfp is the first-pass concentration
of gadolinium in the bloodstream. The relaxiv-
ity of commercial gadolinium chelates are con-
stant over a wide range of magnetic field
strength and is between ∼4 liter/sec/mM (r1)
and ∼6 liter/sec/mM (r2) (see also UNIT B6.4). The
first-pass arterial Gd concentration (Cfp) is an
important factor that determines the overall T1
and T2 at the time of data acquisition and is
related to the circulation status of the patient
(expressed in cardiac output, φ), concentration
of the contrast agent (C), and the injection rate
(Trate). Because of the inverse relationship be-
tween Cfp and φ, it is important to ensure that
when a patient is inside the magnet, he/she is
post-Gd pre-Gd
1,2 1,2 1,2 fpR R r C= + ×
Equation A28.1.1
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Figure A28.1.2 A simulation of the variation in overall signal intensity as a function of RF flip angle
at different longitudinal relaxation times, T1. The optimum flip angle for the peak signal shifts towards
high angles as T1 is shortened as shown by the dashed line. The results from this simulation show
that a higher flip angle is suitable for a shorter T1 (from a faster injection) and a longer TR, whereas
a shorter flip angle is suitable at a longer T1 (from slow injection rates) and a short TR. The dashed
line passing through the peaks shows the shift in optimal flip angle as T1 is varied. This simulation
is based on a fixed TR = 3.0 msec. Abbreviation: a.u., arbitrary units.
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more relaxed so that cardiac output remains low
(Brandfonbrener et al., 1955). In most patients,
this can easily be achieved with simple instruc-
tions and education, along with music.
The corresponding expression for T1 and T2
during the peak arterial flow at the region of
interest is given by the following equation
(Shetty et al., 2000):
where, x = 1,2 refers to T1 and T2. These tran-
sient values of T1 and T2 are based on other
variables that are intrinsic and extrinsic to
blood. Figure A28.1.3 shows the relative
changes in T1 and T2 during first pass at differ-
ent injection rates.
Amount of contrast agent
The literature cites various investigators us-
ing a range of contrast agent strategies. One
approach is to administer a fixed amount (40
ml) regardless of patient weight. While this
may help in simplifying the injection protocol,
it may not be economical for patients who do
not require that volume of contrast agent. Many
have advocated imaging with doses of 0.1 or
0.2 mmol/kg. A lower-dose regimen works best
with perfect bolus timing, a rapid injection rate,
and faster scan times. Higher doses may help
increase signal with proper injection rates to
coincide with the scan duration. At the authors’
institution, a single-dose (0.1 mmol/kg) con-
trast agent protocol is calculated based on the
weight of the patient. A general rule is to use 1
ml for each 10 lb. of patient weight.
Optimum injection rate
It is clear from Fig. A28.1.3 that at an injec-
tion rate beyond ∼2.5 ml/sec, there are no sig-
nificant changes in T1 and T2 values. It is also
possible that at an injection rate higher than 3
ml/sec, signal loss from T2* effect will start to
dominate and overwhelm the gain from T1
enhancement effects. A higher injection rate
necessitates the use of shorter imaging time
(with lower doses) to fit the injection duration.
The other consequence of shortening the scan
time by reducing TR is the increase in band-
width (causing higher noise). A reasonable rate
of injection is ∼2.5 ml/sec with a single dose.
For a consistent injection rate throughout the
scan period, an MR-compatible power injector
is recommended.
Optimum TE
Scanners equipped with high-performance
gradients allow for a much shorter TE. The
advantage of having a short TE is that the sus-
ceptibility-induced dephasing (T2*) artifacts
are greatly reduced. This may be useful in
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Figure A28.1.3 The relative changes in T1 and T2 as a function of injection rate. First-pass values
of T1 and T2 do not change significantly when the injection rate is increased beyond 2.5 ml/sec. A
reasonable injection rate would be between 1.5 and 2.5 ml/sec.
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imaging the lungs, where the air-tissue inter-
face may cause magnetic susceptibility artifact.
With a renal MRA, it is helpful in minimizing
metallic susceptibility artifact originating from
surgical clips or stents. However, shortening the
TE may have an inadvertent effect on widening
the bandwidth, causing a lower signal-to-noise
ratio. Also, a choice of shorter TE may have an
effect on fat-water signal cancellation, causing
a signal loss artifact at tissue boundaries. An
appropriate choice of TE is the minimum
achievable by the scanner at a reasonable re-
ceiver bandwidth of ∼350 to 450 Hz/pixel for
an MRA sequence (sequences 4 and 5).
Optimum TR
The reduction in overall scan time can be
achieved by reducing the TR. Most scanners
allow for a TR as short as 1.5 msec. However,
the reduction in TR is a direct effect of widening
the receiver bandwidth. The reduction of TR is
also achieved by using narrow RF pulses. Most
newer scanners provide shorter RF pulse
lengths for 3-D MRA. However, this has an
effect of aliasing along the slice-select direc-
tion, rendering many end partitions useless.
Selection of TR is made based on the required
scan time for 512 sampling points to fit within
the injection duration. Frequently, the scan time
with a very short TR can be matched with a
shorter injection duration and an appropriate
rate of injection. Although a short TR provides
minimum signal, and, consequently, a lower
signal-to-noise ratio (SNR), the effect of rap-
idly injecting the contrast agent creates a coun-
terbalancing increase in the signal-to-noise ra-
tio (SNR).
Optimum flip angle
The optimum flip angle depends upon the
TR/T1 ratio, which depends on the injection rate.
While any reasonable choice of flip angle may
provide a good signal, it may not be optimal
given the other parameters. At the authors’
institution, a flip angle of 25° is used with a TR
∼4 to 5 msec, whereas a flip angle of 15° is used
with a shorter TR (Fig. A28.1.2).
Bolus arrival (transit) time
The peak enhancement is visualized with the
arrival of a bolus during the first pass. The peak
signal is found when the bolus arrival coincides
with the time corresponding to the central k-
space of the data acquisition. Thus, the knowl-
edge of the bolus arrival time at the intended
target is an important first step in the optimiza-
tion of the protocol. This is particularly chal-
lenging in contrast-enhanced MRA, as the bo-
lus arrival time varies from patient to patient
depending on circulation time and cardiac out-
put. Other timing strategies include automated
bolus detection (Ho and Foo, 1998) and MR
fluoroscopy (Willman et al., 1997). The
authors’ approach was to use a small amount
(∼2 ml) of contrast agent for estimating bolus
arrival time and use the remaining amount for
the full contrast agent injection as described in
steps 21 and 26.
Effects of bolus timing
The signal component of the data is con-
tained in the central portion of k-space (Shetty
et al., 1998). Also, the signal peaks during
maximum arterial concentration, which is
reached during the first-pass phase of arterial
circulation. In an ideal situation, the contrast
agent must be delivered in such a way that the
arterial phase occurs during the central portion
of k-space. Based on the transit time of the
bolus, one can set up imaging parameters in the
sequence delayed to acquire the data during the
peak signal. The scan time and the type of scan
order in lines will determine the delay time
from the injection. Due to the symmetric tem-
poral location of k-space, the scan delay time
was set up for a reverse centric sequence as:
where Tdelay is the measured sequence delay
time from the start of the injection, TBAT is the
experimentally determined bolus arrival time,
and Tacq is the data acquisition time for a single
measurement. Notice that the term (injection
duration)/2 was added to Tdelay in order to ac-
count for the delayed arterial peak with full-
dose injection when compared with test bolus
dose (Fig. A28.1.4). The possible options are
shown in Figure A28.1.5, in which the acquisi-
tion of the central 2⁄3 of the k-space is shown
with respect to the bolus profile. In all, the
signal is based on the relative position of the
central k-space with respect to the bolus arrival
(Ito et al., 1997). If the central k-space is
spanned too early or too late with respect to the
bolus peak, the signal will be poor for arteries.
The best situation is when the contrast agent is
present throughout the data acquisition, which
is usually the case when slow infusion bolus is
used (Fig. A28.1.5A). In this case, high signal
is maintained for all k-space data. However, a
long injection time is necessary to span the
entire k-space, requiring more contrast agent.
( ) ( )delay BAT acq injection duration/ 2 / 2T T T= − +
Equation A28.1.3
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Figure A28.1.4 The bolus arrival time differs with different amounts of injected contrast agent as
shown in this graph. The test bolus (2 ml) plot is shown in square boxes and the injection of an
amount (16 ml) is shown in diamond boxes. Both are injected at 1.5 ml/sec followed by a 15-ml
saline flush at the same rate. The shift in peak position increases with injection duration and is
approximated in Equation A28.1.3. Abbreviation: a.u., arbitrary units.
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Figure A28.1.5 (A) With a reverse centric ordered pulse sequence where the center of k-space lies in
the middle of the acquisition window, the injection rate is adjusted so that its duration spreads across the
acquisition window. (B) With a tight bolus, injection rate is increased and its duration is shorter than the
acquisition window but spreads at least 2/3 of the range. This is an ideal situation. ∆, duration of data
acquisition; t/∆, shows fraction of k-space covered.
Current Protocols in Magnetic Resonance Imaging Supplement 11
A28.1.13
Magnetic
Resonance
Angiography
On the other hand, an ideal situation is when a
tight bolus injection is used with a bolus spread
that enhances 2/3 of the k-space including the
central k-space frequencies (Fig. A28.1.5B).
Anticipated Results
Post-processing of data
The maximum intensity projection (MIP)
processing of subtracted data for rendering ves-
sels can be performed on a main console, on a
satellite console, or on a stand-alone worksta-
tion. Most scanners and workstations do pro-
vide standard software that provides MIP proc-
essing (Figs. A28.1.6 and A28.1.7). In addition,
some workstations provide the capability to
perform volume rendering of the data. MIP
images are produced with a ray-tracing algo-
rithm. Images are stacked together and a ray is
cast through a single pixel in the same location
of all image slices to pick the highest (maxi-
mum) intensity and project it on a plane per-
pendicular to the ray. By orienting the ray at an
angle, another projection image is formed. The
projection images are obtained at various view
angles from 0° to 360°. These projection im-
ages can be viewed in a cine loop to provide a
3-D rotational perspective. Sometimes, choos-
ing a target volume is helpful in minimizing the
processing time and removing the presence of
other high-intensity structures that are not ves-
sels. A major drawback in MIP is the stepladder
effect when a view angle is away from the
normal projection to the slices. This becomes
progressively worse as the view angle is in-
creased (Anderson et al., 1990).
Subtraction process
Use of pre-Gd MASK images to remove
surrounding unenhanced soft tissue signal pro-
Figure A28.1.6 Normal bilateral renal arteries. The bolus arrival timing was estimated by placing
a transverse slice at the mid field-of-view or center of the coronal image. The injection rate was 2.5
ml/sec and the amount of Gd contrast agent was based on a single dose strength (0.1 mmol/kg)
and patient weight. The bolus injection of contrast agent was followed by a 15-ml saline injection at
the same rate.
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vides images similar to those obtained in a
digital subtraction angiography (DSA; Watan-
abe et al., 1998). Most CE-MRA methods use
a 3-D-FLASH (fast low angle shot)-type pulse
sequence with RF spoiling. The purpose of RF
spoiling is to remove any residual transverse
magnetization following the data acquisition,
which helps reduce background tissue signal.
This type of spoiling further improves T1 con-
trast against reduced background signal. Al-
though the background suppression is not fully
achievable with RF spoiling alone, additional
background suppression is achieved by using
the subtraction method at the expense of a loss
in SNR. Many institutions use an additional fat
saturation pulse to suppress the fat signal,
which has an isointense appearance with blood
signal following the injection. However, this is
achieved at the expense of an increase in scan
time. Another way to reduce the fat signal is to
use a TE that corresponds to a fat-water out-of-
phase image to minimize the fat signal. The
downside of this technique is the presence of
prominent signal loss artifact at the fat-tissue
boundaries. Using MASK images to subtract
the surrounding background tissue signal ap-
pears to be appropriate given the short TR.
Another reason for using the subtraction tech-
nique is to remove signal enhancement from
collecting systems that were present due to a
small amount of contrast agent injected during
the test bolus procedure.
Breath-holding
In some cases where patients find it very
difficult to hold their breath despite administer-
Figure A28.1.7 An image of a bilateral renal artery stenosis. The left renal artery (arrow) appears
occluded; however, a slight hypoperfusion in the left kidney possibly indicates a critical stenosis and
not an occlusion. This was confirmed by viewing source images. In addition, iliac artery stenosis at
the origin (arrowhead) is visualized along with an aneurysm of the aorto-iliac junction.
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ing oxygen and hyperventilation, one might
consider reducing the scan time to ∼3 to 4 sec
by reducing either the number of slices or the
acquisition matrix size. The latter change will
severely compromise the spatial resolution.
The advantage of using short-time acquisition
techniques is that time-resolved imaging can be
generated. In this case, the estimating of bolus
arrival time may not be crucial. With the num-
ber of repetitions increased to 7 to 8 and the
patient freely breathing, at least one, if not
several, of the repetitions (measurements) will
acquire data during peak arterial concentration.
Presence of stent
The presence of any metal tends to dephase
the spin signal significantly, causing a wide
halo of dark signal around the metal location
(Fig. A28.1.8). MRA is still a robust technique
for evaluating in-stent stenosis. Although, there
is signal loss around the region where the stent
is placed, one can use phase-contrast imaging
to assess the flow beyond a stent. Using an
electro-cardiograph (ECG)-triggered phase-
contrast imaging sequence (see Table A28.1.7),
multiple images (different phases of the same
imaging slice) are obtained during the entire
cardiac cycle. The selection of a proper velocity
encoding (Venc), at 150 cm/sec, is important to
eliminate any aliasing. This is compared to flow
at the same level in the renal artery from a
normal kidney. A prolonged rise time (defined
as time from onset of systole to the first systolic
peak) beyond 70 msec is considered to be indi-
Figure A28.1.8 An image from a patient with a left renal artery stent. The presence of a stent
(arrow) was visualized from the loss of signal. CE-MRA is a useful technique in visualizing the
presence of a stent, but not very useful in evaluating stenosis within the stent. This is accomplished
by further imaging using a triggered phase-contrast technique. The flow is estimated at the level of
the stent and is compared with flow in the opposite kidney at the same level.
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rect evidence for stenosis within the stent based
on the Doppler literature for the assessment of
renal artery stenosis (Desberg et al., 1990). At
the authors’ institution, flow assessment is per-
formed in patients with renal artery stents for
excluding in-stent stenoses.
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